Cellectis S.A.
ALCLS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €151,657 | €160,354 | €96,832 | €379,179 |
| - Cash | €143,251 | €136,708 | €97,697 | €186,135 |
| + Debt | €91,461 | €85,056 | €82,849 | €102,239 |
| Enterprise Value | €99,867 | €108,702 | €81,984 | €295,283 |
| Revenue | €41,506 | €755 | €19,171 | €73,949 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Gross Profit | €41,506 | €18 | €17,399 | €37,674 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| EBITDA | -€9,462 | -€92,636 | -€76,378 | -€85,437 |
| % Margin | -22.8% | -12,269.7% | -398.4% | -115.5% |
| Net Income | -€36,761 | -€101,059 | -€98,688 | -€86,280 |
| % Margin | -88.6% | -13,385.3% | -514.8% | -116.7% |
| EPS Diluted | -0.41 | -1.92 | -2.17 | -1.93 |
| % Growth | 78.6% | 11.5% | -12.4% | – |
| Operating Cash Flow | €22,989 | -€24,746 | -€87,444 | -€104,562 |
| Capital Expenditures | -€3,843 | -€1,073 | -€2,441 | -€19,743 |
| Free Cash Flow | €19,146 | -€25,819 | -€89,885 | -€124,305 |